- Duloxetine and pregnancy outcomes: safety surveillance findingsSharon L Hoog
Eli Lilly and Company, Indianapolis, IN 46285, USA
Int J Med Sci 10:413-9. 2013..There are no adequate and well-controlled studies in pregnant women treated with duloxetine. Post-marketing surveillance is an important tool for the assessment of drug safety in pregnancy in a naturalistic setting...